National Centre for Clinical Research on Emerging Drugs (NCCRED) is releasing grants to fund innovative clinical research for the treatment of substance use disorder due to methamphetamine or emerging drugs of concern. Capacity building grants
This funding will provide financial support as a value-add to currently established investigator-initiated clinical trials. Applicants are encouraged to apply for funding that will enable the study to answer additional study questions, build research capacity, and produce translational research results. The initial funding round specifically targets proposals investigating treatment options for methamphetamine use disorder. Download guidelines and application form Seed funding grants
This funding will provide financial support as a seed-funding grant to establish investigator-initiated clinical trials / treatment research. The initial funding round specifically targets proposals investigating treatment options for substance use disorder due to methamphetamine or emerging drugs of concern. Download guidelines and application form Applications
Grant applications will be reviewed by the independent National Clinical Research Network—methamphetamine and emerging drugs working group. All round one funding applications are due to be submitted by email to: firstname.lastname@example.org by 28 October 2018.
To discuss the application, or for further information, please contact Krista Siefried on 0410 360 102 or email Krista.email@example.com.
Mentorship for application development / completion is available. Please contact NCCRED.
NADA proudly acknowledges the Gadigal people of the Eora Nation as the custodians of the land on which our office stands. We extend this acknowledgement to all Aboriginal and Torres Strait Islander people across Australia and pay our respects to Elders past, present and future.
NADA is accredited under the Australian Services Excellence Standards (ASES) a quality framework certified by Quality Innovation and Performance (QIP).